First, it may be that although some ER+ BRCA1 breast cancers develop from complete loss of BRCA1 function, others still have intact BRCA1 function resulting in tumors that as a group have phenotypic features that are intermediate between ER- BRCA1 and ER+ sporadic breast cancers. This evidence concerns the gene ESR1 and breast cancer.